Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934096 · ClinicalTrials.gov registry record · NA
Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.
A NA study, sponsored by Northwell Health.
- Not yet
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT06934096: Clinical Trial NA study, sponsored by Northwell Health.
NCT06934096 is a NA study that has not yet begun recruiting, run by Northwell Health. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06934096, a NA study, has not yet begun recruiting, sponsored by Northwell Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This is a three-cohort, randomized, double-blinded , sham-controlled, single-center, early feasibility research trial to determine whether organ-specific biologic effects on platelet activity and coagulation are achievable through selective ultrasound of the spleen utilizing low-energy (diagnostic-level) insonification. * Group 1: Focused insonification at center of the spleen. * Group 2: Prolonged duration insonification at center of the spleen * Group 3: Prolonged duration insonification across the spleen. Participants will receive 30 minutes of sham stimulation in the randomized group that is assigned to them, followed by active stimulation within the same group. Blood biomarkers (local and systemic) will be measured before and at several timepoints after stimulation to measure the molecular and cellular effects of the device
Primary Outcome
The primary objective is to determine whether diagnostic-level ultrasound to the spleen can modulate systemic blood biomarkers of hemostasis.
Interventions
- DEVICE Ultrasound Pulsed Doppler Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2026-05-12 |
| Phase | NA |
What is known before NCT06934096 opens enrollment
NCT06934096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Ultrasound Pulsed Doppler Imaging System is the first listed.
NCT06934096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06934096 about?
NCT06934096 is a clinical study titled "Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.". This is a three-cohort, randomized, double-blinded , sham-controlled, single-center, early feasibility research trial to determine whether organ-specific biologic effects on platelet activity and coagulation are achievable through selective ultrasound of the spleen utilizing low-energy (diagnostic-l...
What is the current status of trial NCT06934096?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2025-04-15. Estimated completion is 2026-05-12.
What interventions are being tested in trial NCT06934096?
The interventions under investigation include: Ultrasound Pulsed Doppler Imaging System (DEVICE).
Who is sponsoring clinical trial NCT06934096?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06934096's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI